Nothing but net
11 July 2018
Email
Share
Agreeing to freeze the price of treatments takes the U.S. firm out of the president’s unpleasant spotlight, but an increase may still be enacted by the end of the year. The sector’s opacity and complexity means posted prices have only a vague relationship to what consumers pay.
This content is for Subscribers only
To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.